{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T05:38:04Z","timestamp":1785821884848,"version":"3.56.0"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,2,4]],"date-time":"2025-02-04T00:00:00Z","timestamp":1738627200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,2,4]],"date-time":"2025-02-04T00:00:00Z","timestamp":1738627200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["npj Digit. Med."],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>Digital therapeutics (DTx) are software-driven solutions for prevention, treatment, and management of medical conditions. Despite a pro-DTx momentum in China, global DTx trial assessments overlooked the country. We identified 756 DTx trials in China and analyzed their characteristics and quality parameters. Over 70% were funded by governments, hospitals, and universities, with tertiary hospitals in eastern China leading most trials. 44.8% used automated DTx, with 39.2% DTx-guided. Most trials focused on management (52.5%) and treatment (38.1%), with few on prevention (9.4%). Mental, behavioral, or neurodevelopmental disorders represented the leading condition category of focus. Recent declines in median sample size, median duration, and mean number of sites were noted. Only 18% of trials were at low overall risk of bias. While recognizing the rapid development of DTx trials in China, we call for better trial design and methodological rigor, prioritization of preventive and primary care, wider condition category scope, and higher inclusivity.<\/jats:p>","DOI":"10.1038\/s41746-025-01477-6","type":"journal-article","created":{"date-parts":[[2025,2,5]],"date-time":"2025-02-05T08:51:21Z","timestamp":1738745481000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Assessment of priorities, quality, and inclusivity of digital therapeutics trials in China"],"prefix":"10.1038","volume":"8","author":[{"given":"Ziming","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinxin","family":"Xia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weijia","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuguo","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,2,4]]},"reference":[{"key":"1477_CR1","unstructured":"International Organization for Standardization. ISO\/TR 11147:2023\u2014Medical devices\u2014Information to be provided by the manufacturer for medical devices with an intended purpose of supporting or providing a digital therapeutic. https:\/\/www.iso.org\/obp\/ui\/#iso:std:iso:tr:11147:ed-1:v1:en (2023)."},{"key":"1477_CR2","unstructured":"Digital Therapeutics Alliance. What is a DTx? https:\/\/dtxalliance.org\/understanding-dtx\/what-is-a-dtx\/ (2024)."},{"key":"1477_CR3","doi-asserted-by":"publisher","first-page":"e11752","DOI":"10.2196\/11752","volume":"21","author":"ED Hermes","year":"2019","unstructured":"Hermes, E. D., Lyon, A. R., Schueller, S. M. & Glass, J. E. Measuring the Implementation of Behavioral Intervention Technologies: Recharacterization of Established Outcomes. J. Med Internet Res 21, e11752 (2019).","journal-title":"J. Med Internet Res"},{"key":"1477_CR4","unstructured":"Digital Therapeutics Alliance. DTA policy positions. https:\/\/dtxalliance.org\/advancing-dtx\/dta-policy-positions\/ (2024)."},{"key":"1477_CR5","doi-asserted-by":"publisher","first-page":"104110","DOI":"10.1016\/j.drudis.2024.104110","volume":"29","author":"N Vasdev","year":"2024","unstructured":"Vasdev, N., Gupta, T., Pawar, B., Bain, A. & Tekade, R. K. Navigating the future of health care with AI-driven digital therapeutics. Drug Discov. Today 29, 104110 (2024).","journal-title":"Drug Discov. Today"},{"key":"1477_CR6","doi-asserted-by":"publisher","DOI":"10.2196\/47094","volume":"25","author":"Y Sapanel","year":"2023","unstructured":"Sapanel, Y. et al. Economic evaluation associated with clinical-grade mobile app\u2013based digital therapeutic interventions: systematic review. J. Med. Internet Res. 25, e47094 (2023).","journal-title":"J. Med. Internet Res."},{"key":"1477_CR7","doi-asserted-by":"publisher","first-page":"205520762312115","DOI":"10.1177\/20552076231211548","volume":"9","author":"T Liu","year":"2023","unstructured":"Liu, T. et al. Cost-effectiveness analysis of digital therapeutics for home-based cardiac rehabilitation for patients with atrial fibrillation after catheter ablation. Digit Health 9, 20552076231211548 (2023).","journal-title":"Digit Health"},{"key":"1477_CR8","unstructured":"Fujian Provincial People\u2019s Government. Outline of the 14th Five-Year Plan (2021-2025) for National Economic and Social Development and Vision 2035. https:\/\/www.fujian.gov.cn\/english\/news\/202108\/t20210809_5665713.htm (2021)."},{"key":"1477_CR9","unstructured":"Hainan Provincial Health Commission. Notice on organizing the application for Hainan Provincial Digital Therapeutics Clinical Trial Center. https:\/\/wst.hainan.gov.cn\/swjw\/ywdt\/tzgg\/202210\/t20221014_3284669.html (2022)."},{"key":"1477_CR10","unstructured":"People\u2019s Daily Client. The first domestic group standard for digital therapeutics was established in Tianjin Economic-Technological Development Area. Tianjin Economic-Technological Development Area. https:\/\/www.teda.gov.cn\/contents\/19\/32382.html (2024)."},{"key":"1477_CR11","unstructured":"Zhejiang Medical Products Administration. Zhejiang Medical Device Review Center provides remote precision services to digital therapeutics industrial park enterprises. Zhejiang Medical Products Administration. https:\/\/mpa.zj.gov.cn\/art\/2022\/4\/22\/art_1228989351_58928659.html (2022)."},{"key":"1477_CR12","doi-asserted-by":"publisher","DOI":"10.1002\/btm2.10536","volume":"8","author":"P Phan","year":"2023","unstructured":"Phan, P., Mitragotri, S. & Zhao, Z. Digital therapeutics in the clinic. Bioeng. Transl. Med. 8, e10536 (2023).","journal-title":"Bioeng. Transl. Med."},{"key":"1477_CR13","unstructured":"Digital Therapeutics Alliance. U.S. regulatory and reimbursement pathways. https:\/\/dtxalliance.org\/wp-content\/uploads\/2022\/01\/US-Regulatory-and-Reimbursement-Pathways.pdf (2022)."},{"key":"1477_CR14","doi-asserted-by":"publisher","first-page":"1484","DOI":"10.1016\/S0140-6736(15)00342-6","volume":"386","author":"Q Meng","year":"2015","unstructured":"Meng, Q., Fang, H., Liu, X., Yuan, B. & Xu, J. Consolidating the social health insurance schemes in China: towards an equitable and efficient health system. Lancet 386, 1484\u20131492 (2015).","journal-title":"Lancet"},{"key":"1477_CR15","first-page":"650","volume":"104","author":"Chinese Society of Digital Psychosomatic Medicine.","year":"2024","unstructured":"Chinese Society of Digital Psychosomatic Medicine. Consensus Panel on Digital Therapeutics for Insomnia. Zhonghua Yi Xue Za Zhi (Chin.) 104, 650\u2013661 (2024).","journal-title":"Zhonghua Yi Xue Za Zhi (Chin.)"},{"key":"1477_CR16","first-page":"381","volume":"27","author":"China Sleep Research Society.","year":"2024","unstructured":"China Sleep Research Society. Expert Consensus on digital therapies for insomnia in China. Chin. Gen. Pract. (Chin.) 27, 381\u2013390 (2024).","journal-title":"Chin. Gen. Pract. (Chin.)"},{"key":"1477_CR17","first-page":"2757","volume":"103","author":"Chinese Association of Drug Abuse Prevention and Treatment.","year":"2023","unstructured":"Chinese Association of Drug Abuse Prevention and Treatment. Consensus Panel on Digital Therapeutics for Addictive Disorders. Expert consensus on digital therapeutics for addictive disorders. Natl Med. J. China (Chin.) 103, 2757\u20132764 (2023).","journal-title":"Natl Med. J. China (Chin.)"},{"key":"1477_CR18","first-page":"640","volume":"103","author":"Chinese Society of Dementia and Cognitive Impairment.","year":"2023","unstructured":"Chinese Society of Dementia and Cognitive Impairment. Consensus Panel on Digital Therapeutics for Cognitive Impairment. [Chinese expert consensus on digital therapeutics for cognitive impairment (2023 edition)]. Zhonghua Yi Xue Za Zhi (Chin.) 103, 640\u2013647 (2023).","journal-title":"Zhonghua Yi Xue Za Zhi (Chin.)"},{"key":"1477_CR19","doi-asserted-by":"publisher","first-page":"1559","DOI":"10.1377\/hlthaff.2023.00384","volume":"42","author":"A Kumar","year":"2023","unstructured":"Kumar, A. et al. Studies of prescription digital therapeutics often lack rigor and inclusivity. Health Aff. (Millwood) 42, 1559\u20131567 (2023).","journal-title":"Health Aff. (Millwood)"},{"key":"1477_CR20","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2024.e36115","volume":"10","author":"H Yao","year":"2024","unstructured":"Yao, H. et al. A comprehensive survey of the clinical trial Landscape on digital therapeutics. Heliyon 10, e36115 (2024).","journal-title":"Heliyon"},{"key":"1477_CR21","doi-asserted-by":"publisher","first-page":"e222","DOI":"10.1016\/S2589-7500(23)00244-3","volume":"6","author":"BY Miao","year":"2024","unstructured":"Miao, B. Y. et al. Characterisation of digital therapeutic clinical trials: a systematic review with natural language processing. Lancet Digit. Health 6, e222\u2013e229 (2024).","journal-title":"Lancet Digit. Health"},{"key":"1477_CR22","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1002\/cpt.3260","volume":"116","author":"L Masanneck","year":"2024","unstructured":"Masanneck, L. & Stern, A. D. Tracing digital therapeutics research across medical specialties: evidence from ClinicalTrials.gov. Clin. Pharm. Ther. 116, 177\u2013185 (2024).","journal-title":"Clin. Pharm. Ther."},{"key":"1477_CR23","unstructured":"World Health Organization. Global Health Estimates 2021: Disease burden by Cause, Age, Sex, by Country and by Region, 2000\u20132021. https:\/\/www.who.int\/data\/gho\/data\/themes\/mortality-and-global-health-estimates\/global-health-estimates-leading-causes-of-dalys (2024)."},{"key":"1477_CR24","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2023-080634","volume":"14","author":"J Ma","year":"2024","unstructured":"Ma, J. et al. Estimating the economic burden of stroke in China: a cost-of-illness study. BMJ Open 14, e080634 (2024).","journal-title":"BMJ Open"},{"key":"1477_CR25","doi-asserted-by":"publisher","first-page":"1301276","DOI":"10.3389\/fpubh.2023.1301276","volume":"11","author":"M Lu","year":"2023","unstructured":"Lu, M. et al. Health care costs of cardiovascular disease in China: a machine learning-based cross-sectional study. Front. Public Health 11, 1301276 (2023).","journal-title":"Front. Public Health"},{"key":"1477_CR26","doi-asserted-by":"publisher","DOI":"10.1186\/s40880-017-0209-4","volume":"36","author":"HY Huang","year":"2017","unstructured":"Huang, H. Y. et al. Expenditure and financial burden for the diagnosis and treatment of colorectal cancer in China: a hospital-based, multicenter, cross-sectional survey. Chin. J. Cancer 36, 41 (2017).","journal-title":"Chin. J. Cancer"},{"key":"1477_CR27","doi-asserted-by":"publisher","first-page":"e39","DOI":"10.1016\/S2214-109X(17)30445-X","volume":"6","author":"Y Huang","year":"2018","unstructured":"Huang, Y. et al. Ethnicity and maternal and child health outcomes and service coverage in western China: a systematic review and meta-analysis. Lancet Glob. Health 6, e39\u2013e56 (2018).","journal-title":"Lancet Glob. Health"},{"key":"1477_CR28","doi-asserted-by":"publisher","DOI":"10.1186\/s12889-020-10102-y","volume":"21","author":"Y Wu","year":"2021","unstructured":"Wu, Y. et al. Ethnic disparities in stillbirth risk in Yunnan, China: a prospective cohort study, 2010\u20132018. BMC Public Health 21, 136 (2021).","journal-title":"BMC Public Health"},{"key":"1477_CR29","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1177\/0022034520976541","volume":"100","author":"SC Wu","year":"2021","unstructured":"Wu, S. C. et al. Ethnic disparities in dental caries among adolescents in China. J. Dent. Res. 100, 496\u2013506 (2021).","journal-title":"J. Dent. Res."},{"key":"1477_CR30","doi-asserted-by":"publisher","first-page":"2515","DOI":"10.1001\/jama.2017.7596","volume":"317","author":"L Wang","year":"2017","unstructured":"Wang, L. et al. Prevalence and ethnic pattern of diabetes and prediabetes in China in 2013. J. Am. Med. Assoc. 317, 2515\u20132523 (2017).","journal-title":"J. Am. Med. Assoc."},{"key":"1477_CR31","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1377\/hlthaff.2024.00152","volume":"43","author":"A Molnar","year":"2024","unstructured":"Molnar, A. Prescription Digital Therapeutics: Assertions. Health Aff. (Millwood) 43, 897 (2024).","journal-title":"Health Aff. (Millwood)"},{"key":"1477_CR32","doi-asserted-by":"publisher","first-page":"e12869","DOI":"10.2196\/12869","volume":"21","author":"EG Lattie","year":"2019","unstructured":"Lattie, E. G. et al. Digital mental health interventions for depression, anxiety, and enhancement of psychological well-being among college students: systematic review. J. Med. Internet Res. 21, e12869 (2019).","journal-title":"J. Med. Internet Res."},{"key":"1477_CR33","unstructured":"Digital Therapeutics Alliance. DTx value assessment & integration guide. https:\/\/dtxalliance.org\/wp-content\/uploads\/2022\/05\/DTx-Value-Assessment-Guide_May-2022.pdf (2022)."},{"key":"1477_CR34","doi-asserted-by":"crossref","unstructured":"Higgins, J. P. T. et al. Chapter 8: Assessing risk of bias in a randomized trial. In Higgins, J.P.T. et al. Cochrane Handbook for Systematic Reviews of Interventions (Version 6.5). https:\/\/training.cochrane.org\/handbook (2019).","DOI":"10.1002\/9781119536604.ch8"},{"key":"1477_CR35","doi-asserted-by":"crossref","unstructured":"Sterne, J. A. C., Hern\u00e1n, M. A., McAleenan, A., Reeves, B. C. & Higgins, J. P. T. Chapter 25: Assessing risk of bias in a non-randomized study. In Higgins, J.P.T. et al. Cochrane Handbook for Systematic Reviews of Interventions (Version 6.5). https:\/\/training.cochrane.org\/handbook (2019).","DOI":"10.1002\/9781119536604.ch25"},{"key":"1477_CR36","doi-asserted-by":"publisher","unstructured":"Pandas Development Team. Pandas (Version 1.3.3) https:\/\/doi.org\/10.5281\/zenodo.3509134 (2021).","DOI":"10.5281\/zenodo.3509134"},{"key":"1477_CR37","doi-asserted-by":"publisher","first-page":"3021","DOI":"10.21105\/joss.03021","volume":"6","author":"ML Waskom","year":"2021","unstructured":"Waskom, M. L. seaborn: Statistical data visualization. J. Open Source Softw. 6, 3021 (2021).","journal-title":"J. Open Source Softw."}],"container-title":["npj Digital Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41746-025-01477-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41746-025-01477-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41746-025-01477-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,5]],"date-time":"2025-02-05T08:51:31Z","timestamp":1738745491000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41746-025-01477-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,4]]},"references-count":37,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["1477"],"URL":"https:\/\/doi.org\/10.1038\/s41746-025-01477-6","relation":{},"ISSN":["2398-6352"],"issn-type":[{"value":"2398-6352","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,4]]},"assertion":[{"value":"8 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 January 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 February 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"83"}}